Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ERIC T RUSH

Allopathic & Osteopathic Physicians Medical Genetics Clinical Genetics (M.D.)

NPI
1952420705
CMS profile
1045350
Location
KANSAS CITY, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$80,937.92

89 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Alexion Pharmaceuticals, Inc. $50,004.34 64
Ultragenyx Pharmaceutical Inc. $29,285.87 18
BioMarin Pharmaceutical Inc. $1,647.71 7

Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ERIC T RUSH

NPI 1952420705 · CMS profile ID 1045350

Allopathic & Osteopathic Physicians / Medical Genetics / Clinical Genetics (M.D.)

KANSAS CITY, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1952420705?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ERIC T RUSH, NPI 1952420705, CMS profile ID 1045350. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1952420705?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). ERIC T RUSH, NPI 1952420705, CMS profile ID 1045350. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1952420705?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
ERIC T RUSH, NPI 1952420705, CMS profile ID 1045350, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1952420705?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

89 matching records · $80,937.92 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 89 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–89 of 89.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alexion Pharmaceuticals, Inc. $800.0006/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114897 CMS
Alexion Pharmaceuticals, Inc. $2,400.0006/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114999 CMS
Ultragenyx Pharmaceutical Inc. $1,200.0006/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976829 CMS
Alexion Pharmaceuticals, Inc. $4.4406/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114861 CMS
Alexion Pharmaceuticals, Inc. $19.1906/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114989 CMS
Alexion Pharmaceuticals, Inc. $77.2106/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783115009 CMS
Alexion Pharmaceuticals, Inc. $145.5906/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783115021 CMS
Alexion Pharmaceuticals, Inc. $77.2006/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114951 CMS
Alexion Pharmaceuticals, Inc. $118.8006/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114977 CMS
Alexion Pharmaceuticals, Inc. $145.5606/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783115019 CMS
Alexion Pharmaceuticals, Inc. $800.0005/18/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114881 CMS
Alexion Pharmaceuticals, Inc. $4.0605/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114857 CMS
Alexion Pharmaceuticals, Inc. $18.9905/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114859 CMS
BioMarin Pharmaceutical Inc. $500.0005/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831400263 CMS
Alexion Pharmaceuticals, Inc. $800.0004/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114899 CMS
BioMarin Pharmaceutical Inc. $17.1604/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831399383 CMS
Ultragenyx Pharmaceutical Inc. $1,200.0004/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976823 CMS
Alexion Pharmaceuticals, Inc. $800.0004/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114875 CMS
Alexion Pharmaceuticals, Inc. $800.0004/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114907 CMS
Ultragenyx Pharmaceutical Inc. $1,200.0004/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976813 CMS
Ultragenyx Pharmaceutical Inc. $200.0004/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976819 CMS
Alexion Pharmaceuticals, Inc. $800.0004/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114885 CMS
Alexion Pharmaceuticals, Inc. $800.0004/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114887 CMS
Alexion Pharmaceuticals, Inc. $800.0004/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114905 CMS
Alexion Pharmaceuticals, Inc. $800.0004/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114893 CMS
Alexion Pharmaceuticals, Inc. $800.0003/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114879 CMS
Alexion Pharmaceuticals, Inc. $800.0003/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114901 CMS
Ultragenyx Pharmaceutical Inc. $1,200.0003/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976803 CMS
Ultragenyx Pharmaceutical Inc. $2,300.0003/23/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976809 CMS
Alexion Pharmaceuticals, Inc. $800.0003/18/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114877 CMS
Alexion Pharmaceuticals, Inc. $800.0003/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114883 CMS
Ultragenyx Pharmaceutical Inc. $3,200.0003/03/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976883 CMS
Alexion Pharmaceuticals, Inc. $800.0003/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114889 CMS
Alexion Pharmaceuticals, Inc. $800.0003/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114895 CMS
Ultragenyx Pharmaceutical Inc. $25.8702/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848976844 CMS
Alexion Pharmaceuticals, Inc. $800.0002/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114891 CMS
BioMarin Pharmaceutical Inc. $500.0002/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831399015 CMS
BioMarin Pharmaceutical Inc. $500.0001/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831399057 CMS
Alexion Pharmaceuticals, Inc. $1,200.0001/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783114903 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $58,272.49 91
PY2020 $75,117.08 68
PY2021 $80,937.92 89
PY2022 $94,040.58 92
PY2023 $140,178.21 135
PY2024 $179,152.14 182
PY2025 $151,613.15 147

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $378,030.08 74
PY2024 Principal investigator $334,545.16 82
PY2023 Principal investigator $362,282.48 25
PY2022 Principal investigator $54,232.23 8
PY2021 Principal investigator $22,209.60 50

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

74 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alexion Pharmaceuticals, Inc. $949.98 12/01/2025 Non-covered Recipient Entity
THE CHILDRENS MERCY HOSPITAL
A Prospective Observational Sub Study of the Global Hypophosphatasia Registry to Evaluate the Potential Risk of Immune Mediated Loss of Pharmacological Effect of Asfotase Alfa in Participants with Hypophosphatasia. No dispute reported 06/30/2026 1185556111
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,696.41 11/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159896
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,128.33 11/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159898
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $364.50 11/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159902
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,350.00 11/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159908
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,350.00 11/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159910
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,174.50 11/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159912
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,914.18 11/03/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159916
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $909.90 10/03/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159900
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $36.10 10/03/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159904
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $4,050.00 10/03/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159906
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,012.50 10/03/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159914
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,569.73 09/23/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159894
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,569.73 08/26/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159884
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,661.53 08/26/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159886
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $19,333.08 08/04/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159784
Principal investigator 1 Alexion Pharmaceuticals, Inc. $76,906.60 07/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
A Phase 3, Randomized, Open-label, Parallel-arm, Active-controlled, Multicenter Study to Evaluate Safety and Efficacy of ALXN1850 Versus Asfotase Alfa Administered Subcutaneously in Pediatric Participants (2 to less than 12 years of age) with Hypophosphatasia (HPP) Previously Treated with Asfotase Alfa No dispute reported 06/30/2026 1185556107
Principal investigator 1 Alexion Pharmaceuticals, Inc. $60,990.00 07/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN1850 Versus Placebo Administered Subcutaneously in Pediatric (2 to 12 years of age) Participants with Hypophosphatasia Who Have Not Received Previous Treatment with Asfotase Alfa No dispute reported 06/30/2026 1185556119
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $36.10 07/17/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159888
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,364.85 07/17/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159890
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $938.00 07/17/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159892
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $19,480.50 07/01/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159786
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $3,082.06 06/24/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159838
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,819.80 06/12/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159846
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $6,519.97 06/12/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159874
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $36.10 06/12/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159882
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $3,249.46 06/05/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159880
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $243.00 05/22/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159852
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,025.00 05/22/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159870
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,885.87 05/22/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159876
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,541.03 05/15/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159844
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,624.73 05/15/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159850
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,351.03 05/08/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159860
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $3,249.46 05/08/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159864
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $3,871.81 04/28/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159840
Principal investigator 1 Alexion Pharmaceuticals, Inc. $2,023.20 04/23/2025 Non-covered Recipient Entity
THE CHILDRENS MERCY HOSPITAL
An Observational, Longitudinal, Prospective, Long term Registry of Patients with Hypophosphatasia No dispute reported 06/30/2026 1185556109
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,624.73 04/15/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159842
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,541.03 04/15/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159848
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $9,084.19 04/08/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159862
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $49.95 04/01/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159854
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,025.00 04/01/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159856
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $9,384.13 04/01/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159858
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $675.00 04/01/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159866
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $6,480.00 04/01/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159868
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,012.50 04/01/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159872
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $3,969.00 04/01/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159878
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $82.35 03/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159800
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,319.30 03/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159806
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,541.03 03/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159816
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $36.10 03/25/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159818
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $6,791.32 03/11/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159822
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,624.73 03/04/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159796
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,351.03 03/04/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159814
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $49.95 02/18/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159808
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $5,063.19 02/13/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159824
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $10,164.87 02/05/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159798
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $9,384.13 02/05/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159804
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $3,791.48 02/05/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159832
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $36.10 02/05/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159834
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $82.35 02/05/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159836
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $15,022.80 02/03/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159788
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $7,813.84 01/29/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159810
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $532.00 01/29/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159812
Principal investigator 1 Alexion Pharmaceuticals, Inc. $8,646.00 01/27/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
A Prospective Observational Sub Study of the Global Hypophosphatasia Registry to Evaluate the Potential Risk of Immune Mediated Loss of Pharmacological Effect of Asfotase Alfa in Participants with Hypophosphatasia. No dispute reported 06/30/2026 1185556115
Principal investigator 1 Alexion Pharmaceuticals, Inc. $14,685.40 01/22/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
An Observational, Longitudinal, Prospective, Long term Registry of Patients with Hypophosphatasia No dispute reported 06/30/2026 1185556117
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $121.50 01/21/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159790
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $3,220.75 01/17/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159792
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $3,709.81 01/17/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159820
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $36.10 01/17/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159826
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $2,351.03 01/17/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159828
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,541.03 01/07/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL314 No dispute reported 06/30/2026 1253159794
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,774.58 01/07/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159802
Principal investigator 1 Ultragenyx Pharmaceutical Inc. $1,624.73 01/07/2025 Covered Recipient Teaching Hospital
Childrens Mercy Hospital
UX143-CL301 No dispute reported 06/30/2026 1253159830
Principal investigator 1 Alexion Pharmaceuticals, Inc. $478.01 01/02/2025 Non-covered Recipient Entity
CHILDRENS MERCY HOSPITAL
A Prospective Observational Sub Study of the Global Hypophosphatasia Registry to Evaluate the Potential Risk of Immune Mediated Loss of Pharmacological Effect of Asfotase Alfa in Participants with Hypophosphatasia. No dispute reported 06/30/2026 1185556113